Protara Therapeutics (TARA) Stock Chart & Stock Price History → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free TARA Stock Alerts $2.93 -0.06 (-2.01%) (As of 05/21/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Protara Therapeutics Stock Price Performance5 Day Performance-21.66%1 Month Performance+10.98%3 Month Performance-28.88%6 Month Performance+157.02%Year-To-Date Performance+56.26%1 Year Performance-4.87% Receive TARA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchWarren Buffett's "mystery stock"WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some TARA Stock Chart for Tuesday, May, 21, 2024 TARA Chart by TradingView Protara Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2024$3.09$2.99-3.24%$3.17$2.84358,866 shs$61.56 million05/17/2024$3.74$3.09-17.38%$3.74$2.95797,808 shs$63.62 million05/16/2024$3.71$3.74+0.81%$3.87$3.52546,288 shs$77.01 million05/15/2024$3.34$3.71+11.08%$3.79$3.321.30 million shs$76.39 million05/14/2024$3.24$3.34+3.09%$3.57$3.21937,415 shs$68.77 million05/13/2024$3.00$3.24+8.00%$3.35$2.99630,731 shs$66.71 million Get the Latest News and Ratings for TARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/10/2024$2.98$3.00+0.67%$3.34$2.87917,005 shs$34.29 million05/09/2024$2.83$2.98+5.30%$3.25$2.81954,429 shs$34.06 million05/08/2024$2.87$2.83-1.39%$2.95$2.80155,506 shs$32.35 million05/07/2024$2.90$2.87-1.03%$3.00$2.8780,072 shs$32.80 million05/06/2024$2.91$2.90-0.34%$3.03$2.88109,132 shs$33.15 million05/03/2024$2.89$2.91+0.69%$2.99$2.84118,886 shs$33.26 million05/02/2024$2.93$2.89-1.37%$3.00$2.85113,561 shs$33.03 million05/01/2024$2.98$2.93-1.68%$3.20$2.87250,728 shs$33.49 million04/30/2024$3.10$2.98-3.87%$3.11$2.84280,350 shs$34.06 million04/29/2024$2.93$3.10+5.98%$3.16$2.86782,481 shs$35.43 million04/26/2024$3.05$2.92-4.26%$3.23$2.83254,929 shs$33.39 million04/25/2024$2.82$3.05+8.16%$3.05$2.75262,559 shs$34.86 million04/24/2024$3.00$2.82-6.00%$3.11$2.80422,081 shs$32.23 million04/23/2024$3.05$3.00-1.64%$3.18$2.82411,621 shs$34.29 million04/22/2024$2.64$3.05+15.53%$3.35$2.89536,374 shs$34.86 million04/19/2024$2.75$2.64-4.00%$2.80$2.61207,887 shs$30.18 million04/18/2024$2.73$2.75+0.73%$2.89$2.66241,473 shs$31.43 million04/17/2024$2.85$2.73-4.21%$2.84$2.70174,414 shs$31.22 million04/16/2024$2.84$2.85+0.35%$2.93$2.73133,639 shs$32.58 million04/15/2024$3.00$2.84-5.33%$3.02$2.82137,294 shs$32.46 million04/12/2024$3.09$3.00-2.91%$3.15$2.92144,474 shs$34.30 million04/11/2024$3.19$3.09-3.13%$3.19$2.93114,769 shs$35.32 million04/10/2024$3.22$3.19-0.93%$3.39$3.12130,328 shs$36.46 million04/09/2024$3.43$3.22-6.12%$3.44$3.16401,491 shs$36.81 million04/08/2024$3.63$3.43-5.51%$3.69$3.36354,093 shs$39.21 million04/05/2024$4.02$3.63-9.70%$5.24$3.568.57 million shs$41.49 million04/04/2024$4.10$4.02-1.95%$4.20$3.9830,820 shs$45.95 million04/03/2024$4.11$4.10-0.24%$4.15$4.0352,681 shs$46.86 million04/02/2024$4.14$4.11-0.72%$4.14$3.9541,939 shs$46.98 million04/01/2024$4.01$4.14+3.24%$4.14$3.9977,712 shs$47.32 million03/29/2024$4.01$4.01$4.10$3.9584,083 shs$45.83 million03/28/2024$4.00$4.01+0.25%$4.10$3.9583,563 shs$45.83 million03/27/2024$4.15$4.00-3.61%$4.23$3.9568,424 shs$45.72 million03/26/2024$3.99$4.15+4.01%$4.20$3.9285,958 shs$47.44 millionEverybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade.03/25/2024$4.02$3.99-0.75%$4.12$3.9139,284 shs$45.61 million03/22/2024$3.90$4.02+3.08%$4.25$3.9685,262 shs$45.95 million03/21/2024$4.03$3.90-3.23%$4.22$3.89146,029 shs$44.58 million03/20/2024$4.00$4.03+0.75%$4.25$3.9052,908 shs$46.06 million03/19/2024$4.00$4.00$4.04$3.8788,610 shs$45.72 million03/18/2024$3.68$4.00+8.70%$4.13$3.73210,818 shs$45.72 million03/15/2024$3.57$3.68+3.08%$3.73$3.40106,606 shs$41.81 million03/14/2024$3.65$3.57-2.19%$3.72$3.4455,213 shs$40.57 million03/13/2024$3.57$3.65+2.24%$3.79$3.6055,077 shs$41.48 million03/12/2024$3.57$3.57$3.66$3.4550,263 shs$40.56 million03/11/2024$3.80$3.57-6.05%$3.92$3.4391,984 shs$40.56 million03/08/2024$3.83$3.80-0.78%$4.00$3.7632,217 shs$43.17 million03/07/2024$3.95$3.83-3.04%$4.16$3.7543,474 shs$43.51 million03/06/2024$3.74$3.95+5.61%$4.23$3.6523,887 shs$44.87 million03/05/2024$4.40$3.74-15.00%$4.42$3.63117,613 shs$42.49 million03/04/2024$4.60$4.40-4.35%$4.74$4.2281,835 shs$49.98 million03/01/2024$4.56$4.60+0.88%$4.72$4.3294,393 shs$52.26 million02/29/2024$4.47$4.56+2.01%$4.84$4.4046,441 shs$51.80 million02/28/2024$4.83$4.47-7.45%$4.91$4.33136,465 shs$50.78 million02/27/2024$4.69$4.83+2.99%$4.95$4.75154,623 shs$54.87 million02/26/2024$4.21$4.69+11.40%$4.70$4.25143,324 shs$53.28 million02/23/2024$4.08$4.21+3.19%$4.41$3.9784,653 shs$47.83 million02/22/2024$4.12$4.08-0.97%$4.33$3.9574,038 shs$46.35 million02/21/2024$3.99$4.12+3.26%$4.23$3.9070,311 shs$46.80 million02/20/2024$4.06$3.99-1.72%$4.42$3.87153,406 shs$45.33 million Related Companies: TSBX Stock Price Chart ENTX Stock Price Chart ATRA Stock Price Chart IKNA Stock Price Chart CVM Stock Price Chart TIL Stock Price Chart CDTX Stock Price Chart GNTA Stock Price Chart CGTX Stock Price Chart AVRO Stock Price Chart Receive TARA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TARA) was last updated on 5/21/2024 by MarketBeat.com Staff From Our Partners"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.